Cardinal Capital Management INC Lifted Position in Amgen INC (AMGN) by $9.77 Million as Stock Value Declined

April 17, 2018 - By Migdalia James

Amgen Inc. (NASDAQ:AMGN) LogoInvestors sentiment increased to 1.22 in 2017 Q4. Its up 0.23, from 0.99 in 2017Q3. It increased, as 73 investors sold AMGN shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. 14,336 were reported by Amg Natl Trust Commercial Bank. Georgia-based First City Capital Management has invested 0.46% in Amgen Inc. (NASDAQ:AMGN). Rhumbline Advisers has 1.41M shares. Sequoia Finance Advsrs Limited Liability Company reported 4,785 shares. Rodgers Brothers accumulated 4,458 shares. Verity & Verity Ltd Liability holds 14,609 shares or 0.79% of its portfolio. Cubic Asset Mngmt Limited Liability Company holds 0.1% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 2,046 shares. Community And Inv invested in 0.03% or 1,590 shares. Nichols Pratt Advisers Llp Ma has 5,087 shares. Eaton Vance Management reported 1.22 million shares or 0.52% of all its holdings. Numeric Invsts Ltd Liability stated it has 0.85% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Parametric Assoc Lc accumulated 2.35 million shares. Parsec Finance stated it has 133,928 shares or 1.58% of all its holdings. Cullen Frost Bankers Incorporated reported 0.25% in Amgen Inc. (NASDAQ:AMGN). Louisiana-based Louisiana State Employees Retirement Systems has invested 0.35% in Amgen Inc. (NASDAQ:AMGN).

Since December 12, 2017, it had 0 insider buys, and 4 insider sales for $1.11 million activity.

Cardinal Capital Management Inc increased its stake in Amgen Inc. (AMGN) by 1394.81% based on its latest 2017Q4 regulatory filing with the SEC. Cardinal Capital Management Inc bought 56,490 shares as the company’s stock declined 2.99% with the market. The institutional investor held 60,540 shares of the biological products (no diagnostic substances) company at the end of 2017Q4, valued at $10.53M, up from 4,050 at the end of the previous reported quarter. Cardinal Capital Management Inc who had been investing in Amgen Inc. for a number of months, seems to be bullish on the $116.99B market cap company. The stock increased 2.15% or $3.68 during the last trading session, reaching $175.06. About 1.11 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since April 17, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Cardinal Capital Management Inc, which manages about $1.84 billion and $1.18B US Long portfolio, decreased its stake in General Electric Co. (NYSE:GE) by 453,160 shares to 1,100 shares, valued at $19,000 in 2017Q4, according to the filing. It also reduced its holding in Magna International Inc. (NYSE:MGA) by 59,400 shares in the quarter, leaving it with 951,876 shares, and cut its stake in Royal Bank Of Canada (NYSE:RY).

Amgen Inc. (NASDAQ:AMGN) Ratings Coverage

Among 14 analysts covering Amgen Inc (NASDAQ:AMGN), 7 have Buy rating, 0 Sell and 7 Hold. Therefore 50% are positive. Amgen Inc had 22 analyst reports since October 20, 2017 according to SRatingsIntel. The rating was maintained by Mizuho on Sunday, October 29 with “Buy”. Barclays Capital maintained the stock with “Equal-Weight” rating in Thursday, April 5 report. Piper Jaffray maintained Amgen Inc. (NASDAQ:AMGN) rating on Thursday, January 18. Piper Jaffray has “Buy” rating and $194.0 target. The rating was maintained by RBC Capital Markets on Monday, January 22 with “Hold”. The stock has “Buy” rating by Cowen & Co on Thursday, February 1. PiperJaffray maintained it with “Overweight” rating and $190 target in Friday, February 2 report. BMO Capital Markets maintained the stock with “Market Perform” rating in Thursday, October 26 report. On Monday, February 5 the stock rating was downgraded by Atlantic Securities to “Hold”. The firm has “Overweight” rating given on Thursday, October 26 by Morgan Stanley. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Market Perform” rating by BMO Capital Markets on Friday, February 2.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: